Skip to main content
Premium Trial:

Request an Annual Quote

MSK Partners With Cota on Clinical, Genomic Data Sets

CHICAGO (GenomeWeb) – Healthcare analytics technology company Cota has entered into a partnership with New York's Memorial Sloan Kettering Cancer Center.

Cota will take anonymized clinical records from MSK and run it through its Cota Nodal Address classification system to build clinical and genomic data sets. This will have the dual purposes of supporting patient care and research at MSK and augmenting Cota's store of evidence.

Cota Nodal Address creates patient cohorts by categorizing patient-specific medical histories, information on their diseases, and planned therapies. "This organized and analyzed data will help our physicians practice more efficiently, optimizing the care a patient receives based on a variety of characteristics and ultimately can improve outcomes for all cancer patients as this knowledge is shared," Paul Sabbatini, MSK's deputy physician-in-chief for clinical research, said in a statement.

MSK and Cota — previously known as Cancer Outcomes Tracking and Analysis — also said that they would form an unspecified technology collaboration centered around analytics for improving disease classification in oncology.

"Cota's powerful technology platform can thread disparate data into a rich longitudinal record to support hypothesis testing, actionable insights, and evidence based decision-making," said Janhvi Patel, Cota's vice president of strategic partnerships. "This collaboration puts Cota at the forefront of precision medicine, creating one of the richest clinical and genomic databases in cancer to fuel innovation in research and development of new therapies and payer-provider value-based programs."

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.